Rockeby awarded bird flu tests tender from Middle East
Rockeby biomed Ltd announced that it has received its first tender award for its avian influenza Virus kits from the Middle Eastern nation of Jordan.
Rockeby Chief Executive Dr Sze-Wee Tan said the company has been awarded the national tender for 1,500 bird flu tests in Jordan. In addition to this, the company this week has also received separate orders for bird flu tests both from Pasteur Institute's laboratory in Tunisia and from the state of Brunei Darussalam.
"Payment for the Jordan tender has already been received, and the tests will be shipped to Jordan later this month," Dr Tan said. "This together with the Pasteur Institute and the Brunei order further demonstrate the growing acceptance of Rockeby's Avian Influenza Virus test kit in diverse global markets where the threat of Avian Flu still remains. We have tenders for several countries including Italy and Switzerland, which are still pending."
Rockeby's Avian Flu rapid tests have been sold in Singapore, Malaysia, Thailand and other Middle Eastern markets. Rockeby has distributors for Eygpt, Libya, Palestine, UAE, Yemen. The rapid test is currently used by the Thailand and Indonesia government in the bird flu outbreak there.
Topics
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Rentschler focuses on biotechnology

How cancer genes become independent - Study sheds light on the mysterious evolution of DNA rings

Blueprint of Oxytocin Receptor Facilitates Development of New Autism Drugs
Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Provence Technologies and Neuroptis Biotech partner to develop a new compound for treating dry eye syndrome
Mayo researchers develop new laboratory cell lines to study treatment for ATC
Diabetes advance: Researchers find gene that causes resistance to insulin - Discovery is first gene known to affect how insulin works, not how it is produced

ZEISS Ventures invests in life science start-up InSphero to drive 3D cell culture research - Strategic investment is closely linked to ZEISS Research Microscopy Solutions and its capabilities in automated, high-resolution imaging and 3D image analysis

Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing - Culture is closing the gap in manufacturing capacity with its large-scale cloud bioreactors
Mechanical heart valve prosthesis superior to biological
